Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients. - Wikidata - wikimedia - TriplyDB

Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

http://www.wikidata.org/entity/Q37945228

about

From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma.Chronic intermittent hypoxia and hypertension: a review of systemic inflammation and Chinese medicine.The HTLV-1 basic leucine zipper factor (HBZ) attenuates repair of double-stranded DNA breaks via non-homologous end joining (NHEJ).

P2860

Q26774369-9AC971A9-DFCA-462A-B3BF-16C3A83CCB90 Q33581506-F379D4C4-202B-41DA-9A8D-C0238BFB7CB0 Q35945853-79A5A970-BA73-4338-A180-FBEEFAEEE7DC Q38106888-33ABA248-9304-41DE-856C-C3DE0CBEDB0A Q54209627-DDD27CEA-259E-418B-8243-D03352FBBC13

P2860

Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

http://www.wikidata.org/entity/Q37945228

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

@en

Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

@nl

type

label

Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

@en

Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

@nl

prefLabel

Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

@en

Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

@nl

P1433

Q37945228-B6D2A62F-2BF1-4B87-8A0B-B3009D8EA6FF

P1476

Q37945228-6AFE5721-A34B-476A-8DEC-C5FDF4D690EB

P2093

Q37945228-6EBCEDA2-CCF8-414C-91FF-E42CB931B7B4

Q37945228-784889B8-B71B-4D56-83A4-1705F08C4252

P275

Q37945228-8D7B40CA-F859-4635-865E-FA25A093C3F3

P2860

Q37945228-096D22BA-2ADB-40D1-B0DC-8EE8B7E056A3

Q37945228-0AB81101-6147-41B9-AC91-7EBE31E8FCAF

Q37945228-10DD111E-39D3-4CAB-BB4A-1663F8582C6C

Q37945228-189B5690-584B-4BF6-A91D-4BCE73C802BC

Q37945228-1D201679-A675-4103-A9D8-052ED7FA3E18

Q37945228-1DB4A6E2-EE62-4091-B8DC-85346C62E1AB

Q37945228-204A4983-7DB0-47FE-9A2A-C76E97B63322

Q37945228-20A06F8D-C2D9-48CD-992A-426866F08419

Q37945228-2D51D59D-34CE-4F8C-BCC1-A50244E23522

Q37945228-2F588B6D-9695-47B5-BBE7-73FBC38DA617

P304

Q37945228-03C09637-67C1-44AE-AD15-84202CC47316

P31

Q37945228-17F657B2-8705-493E-B915-629D211BEAE5

Q37945228-75C2F978-FF60-4821-9C9A-235FD42EBEEA

P356

Q37945228-0BD89015-24AF-439A-A1AA-6DD8A49800A1

P433

Q37945228-E423B838-A140-40A2-8BFF-A28110615FA1

P478

Q37945228-9FA5AC44-FB73-4CEE-848D-36E5175C0AFC

P5008

Q37945228-104B58BC-A1CB-49DF-BE75-315F7E66824B

P577

Q37945228-99081650-224A-491E-81AE-E293374EBB8C

Q37945228-CC66FF73-61CC-4F77-B377-B171D835B2AA

P5875

Q37945228-E01359DB-BD2F-4EF2-85F3-AFBA386993A9

P698

Q37945228-26BD9FAD-433A-4472-B3C6-7FCC5B7D5180

P921

Q37945228-08C3D2B3-B704-4A2F-AC67-D5BFF0413520

Q37945228-2293F928-7779-4EB4-9C78-79CB77494F1D

Q37945228-580DAFD7-D07B-48A0-849E-22A099B2957F

Q37945228-73BF18E8-D109-44F0-906C-3A80B5C62CC9

Q37945228-AF09F1E5-F826-4EE0-AF54-59D96FC11655

Q37945228-EB936103-516A-493C-A46B-FD87C5DF96EB

P932

Q37945228-955A8FF3-3953-4C06-BC66-740EA35E0532

P356

P1433

P1476

Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

@en

P2093

Daniel A Rauch

http://www.w3.org/2001/XMLSchema#string

Lee Ratner

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signaling

Cancer-related inflammation

Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis.

Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.

T-cell activation promotes tumorigenesis in inflammation-associated cancer.

Bioluminescence imaging of myeloperoxidase activity in vivo.

The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.

Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases.

Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model.

Low CD4/CD8 T-cell ratio associated with inflammatory arthropathy in human T-cell leukemia virus type I Tax transgenic mice.

P304

886-900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/V3060886

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2011-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51712090

http://www.w3.org/2001/XMLSchema#string

P698

21994759

http://www.w3.org/2001/XMLSchema#string

P921

Human T-lymphotropic virus 1

nuclear protein

DNA-binding protein

Adult T-cell leukemia/lymphoma

transcription factor

regulation of gene expression

P932

3185776

http://www.w3.org/2001/XMLSchema#string